The 2019 update to the Canadian Cardiovascular Society (CCS) TAVI position statement emphasizes the importance of individual patient evaluation by a multidisciplinary heart team to determine the optimal treatment decision

A multidisciplinary heart team is a requirement for all TAVI programs in Canada1

TAVI should be performed in centres with experience in high-risk aortic valve surgery and a strong, collaborative multidisciplinary heart team with the expertise to guide patients with severe AS through the decision-making process.1

The decision between TAVI and SAVR should take into consideration the patient’s individual conditions and preferences based on the heart team’s consensus1

For symptomatic patients with severe AS.

The CCS recognizes TAVI as an important treatment option for patients with severe AS. The 2019 Position Statement emphasizes the need to improve quality of care by increasing access to treatments to provide optimal patient outcomes.1

References:   1. Asgar AW, Ouzounian M, Adams C, et al. 2019 Canadian Cardiovascular Society Position Statement for Transcatheter Aortic Valve Implantation: Society Position Statement. Can J Cardiol. 2019:1437-1448. DOI: 10.1016/j.cjca.2019.08.011.